News for GlobeImmune, Inc. (GBIM)

Published at

Feb 24, 2023 1:54 PM

by globenewswire.com

mixed

mixed

At 9.6% CAGR, Global Cancer Gene Therapy Market Size Estimated to Cross USD 3.99 Billion Value By 2030: Polaris Market Research

[115+ Pages Research Study] According to Polaris Market Research report, the global cancer gene therapy market size & share expected to generate revenue of...

NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA KPTI GSK.L GSK GS7.DE GLAXF BRM.DE BMYB34.SA BMY.MX BMY.BA BMY AMGN.MX AMGN.BA AMGN AMG.DE 0K9E.L SRPT ORTX GIS.DE GILDD.BA GILD.MX GILD GBIM 0L35.L

Read more →
Published at

Aug 10, 2022 10:14 AM

by etfdailynews.com

positive

positive

GlobeImmune (OTCMKTS:GBIM) Share Price Crosses Above 50 Day Moving Average of $0.00

Read GlobeImmune (OTCMKTS:GBIM) Share Price Crosses Above 50 Day Moving Average of $0.00 at ETF Daily News

GBIM

Read more →
Published at

Aug 9, 2022 7:28 AM

by etfdailynews.com

mixed

mixed

Reviewing ImmunityBio (NASDAQ:IBRX) & CytRx (NASDAQ:CYTR)

Read Reviewing ImmunityBio (NASDAQ:IBRX) & CytRx (NASDAQ:CYTR) at ETF Daily News

IBRX CYTR 0I5R.L VIRX SRNE GBIM 0L85.L AMRS.MX AMRS

Read more →
Published at

Aug 6, 2022 7:52 AM

by etfdailynews.com

mixed

mixed

ImmunityBio (NASDAQ:IBRX) & Exelixis (NASDAQ:EXEL) Head-To-Head Analysis

Read ImmunityBio (NASDAQ:IBRX) & Exelixis (NASDAQ:EXEL) Head-To-Head Analysis at ETF Daily News

VIRX SRNE IBRX EXEL EX9.DE 0L85.L 0IJO.L GBIM DSNKY DSKYF CYTR 4568.T 0I5R.L BRM.DE BMYB34.SA BMY.MX BMY.BA BMY AMRS.MX AMRS

Read more →
Published at

Jul 19, 2022 9:06 AM

by etfdailynews.com

mixed

mixed

Head-To-Head Review: Poseida Therapeutics (NASDAQ:PSTX) & ImmunityBio (NASDAQ:IBRX)

Read Head-To-Head Review: Poseida Therapeutics (NASDAQ:PSTX) & ImmunityBio (NASDAQ:IBRX) at ETF Daily News

VIRX TKPHF TAKP34.SA TAKN.MX TAK SRNE SARDY PSTX IBRX 4502.T 4502.S 0L85.L 0A87.L GBIM CYTR 0I5R.L AMRS.MX AMRS

Read more →
Published at

May 21, 2022 7:34 AM

by etfdailynews.com

mixed

mixed

ImmunityBio (NASDAQ:IBRX) vs. Halozyme Therapeutics (NASDAQ:HALO) Critical Analysis

Read ImmunityBio (NASDAQ:IBRX) vs. Halozyme Therapeutics (NASDAQ:HALO) Critical Analysis at ETF Daily News

VIRX SRNE IBRX HALO 0L85.L 0J2O.L GBIM CYTR 0I5R.L PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE LLY.MX LLY.DE LLY.BA LLY LILY34.SA BRM.DE BMYB34.SA BMY.MX BMY.BA BMY AMRS.MX AMRS ABBV34.SA ABBV.MX ABBV.BA ABBV 4AB.DE 0Q1G.L

Read more →
Published at

May 8, 2022 7:22 AM

by etfdailynews.com

mixed

mixed

Head-To-Head Contrast: ImmunityBio (NASDAQ:IBRX) versus Revolution Medicines (NASDAQ:RVMD)

Read Head-To-Head Contrast: ImmunityBio (NASDAQ:IBRX) versus Revolution Medicines (NASDAQ:RVMD) at ETF Daily News

RVMD IBRX GBIM CYTR 0I5R.L VIRX SRNE AMRS.MX AMRS 0L85.L

Read more →
Published at

May 4, 2022 7:00 PM

by globenewswire.com

mixed

mixed

Tuberculosis Pipeline Landscape Analysis of 38+ Companies by DelveInsight

Tuberculosis (TB) is a chronic condition and has become a global disease burden. Advanced technologies as well as the introduction of novel therapies are...

GBIM MNKD 000105.KS 000100.KS LLY.MX LLY.DE LLY.BA LLY LILY34.SA 0Q1G.L

Read more →
Published at

Aug 13, 2021 5:30 PM

by prnewswire.com

mixed

mixed

Global Cancer Vaccines Research Report 2021-2026: Leading Players are Merck & Co., GlaxoSmithKline and Dendreon

/PRNewswire/ -- The

MRNA.MX MRNA M1RN34.SA INO.MX INO GBIM CLDX BLCM ANIX ADXS 0A45.L 0A43.L 095700.KQ MRKD.BA MRK.SN MRK.PA MRK.MX MRK GSK.L GSK GS7.DE GLAXF AMGN.MX AMGN.BA AMGN AMG.DE 6MK.DE

Read more →
Published at

Aug 13, 2021 5:30 PM

by markets.businessinsider.com

mixed

mixed

Global Cancer Vaccines Research Report 2021-2026: Leading Players are Merck & Co., GlaxoSmithKline and Dendreon

DUBLIN, Aug. 13, 2021 /PRNewswire/ -- The 'Cancer Vaccines: Technologies and Global Markets 2021-2026' report has been added to ResearchAndMarkets...

MRNA.MX MRNA M1RN34.SA INO.MX INO GSK.L GSK GS7.DE GLAXF GBIM CLDX BLCM ANIX ADXS 0A45.L 0A43.L 095700.KQ MRKD.BA MRK.SN MRK.PA MRK.MX MRK AMGN.MX AMGN.BA AMGN AMG.DE 6MK.DE

Read more →